AAAAAA

   
Results: 1-8 |
Results: 8
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoproteinIIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty
Authors: Akkerhuis, KM van den Brand, MJBM van der Zwaan, C Peels, HOJ Suryapranata, H van der Wieken, LR Stibbe, J Hoffmann, J Baardman, T Deckers, JW Simoons, ML
Citation: Km. Akkerhuis et al., Pharmacodynamics and safety of lefradafiban, an oral platelet glycoproteinIIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty, HEART, 85(4), 2001, pp. 444-450
Coronary restenosis elimination with a sirolimus eluting stent - First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
Authors: Rensing, BJ Vos, J Smits, PC Foley, DP van den Brand, MJBM van der Giessen, WJ de Feijter, PJ Serruys, PW
Citation: Bj. Rensing et al., Coronary restenosis elimination with a sirolimus eluting stent - First European human experience with 6-month angiographic and intravascular ultrasonic follow-up, EUR HEART J, 22(22), 2001, pp. 2125-2130
Long-term clinical outcome after coronary balloon angioplasty - Identification of a population at low risk of recurrent events during 17 years of follow-up
Authors: van Domburg, RT Foley, DP de Feyter, PJ van der Giessen, W van den Brand, MJBM Serruys, PM
Citation: Rt. Van Domburg et al., Long-term clinical outcome after coronary balloon angioplasty - Identification of a population at low risk of recurrent events during 17 years of follow-up, EUR HEART J, 22(11), 2001, pp. 934-941
Feelings of being disabled as a predictor of mortality in men 10 years after percutaneous coronary transluminal angioplasty
Authors: van Domburg, RT Pedersen, SS van den Brand, MJBM Erdman, RAM
Citation: Rt. Van Domburg et al., Feelings of being disabled as a predictor of mortality in men 10 years after percutaneous coronary transluminal angioplasty, J PSYCHOSOM, 51(3), 2001, pp. 469-477
Spontaneous dissections of all three coronary arteries in a 33-week-pregnant woman
Authors: Rensing, BJ Kofflard, M van den Brand, MJBM Foley, DP
Citation: Bj. Rensing et al., Spontaneous dissections of all three coronary arteries in a 33-week-pregnant woman, CATHET C IN, 48(2), 1999, pp. 207-210
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty - Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study
Authors: van den Merkhof, LFM Zijlstra, F Olsson, H Grip, L Veen, G Bar, FWHM van den Brand, MJBM Simoons, ML Verheugt, FWA
Citation: Lfm. Van Den Merkhof et al., Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty - Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study, J AM COL C, 33(6), 1999, pp. 1528-1532
Corneal arcus: indicator for severity of coronary atherosclerosis?
Authors: Hoogerbrugge, N Happee, C van Domburg, R Poldermans, D van den Brand, MJBM
Citation: N. Hoogerbrugge et al., Corneal arcus: indicator for severity of coronary atherosclerosis?, NETH J MED, 55(4), 1999, pp. 184-187
The use of abciximab in therapy resistant unstable angina - Clinical and angiographic results of the CAPTURE pilot and the CAPTURE study
Authors: van den Brand, MJBM Simoons, ML
Citation: Mjbm. Van Den Brand et Ml. Simoons, The use of abciximab in therapy resistant unstable angina - Clinical and angiographic results of the CAPTURE pilot and the CAPTURE study, CONTEMP CAR, 2, 1999, pp. 143-168
Risultati: 1-8 |